Matisse Pharmaceuticals closed a €14 million Series A financing round to advance isupartob sodium through Phase 2 clinical development.
Amount Raised
€14 Million
Round Type
Series A
LimburgBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Matisse Pharmaceuticals B.V. has successfully completed its Series A financing round. The €14 million round was led by existing and new shareholders, including Brightlands Venture Partners and LIOF. The proceeds will be used for the Phase 2 clinical trial of isupartob sodium
Quick answer
Matisse Pharmaceuticals B.V raised €14 Million in a Series A round, dated September 17, 2026. Investors: Liof and Brightlands Venture Partners. Matisse Pharmaceuticals B.V is based in Limburg, Netherlands.
- How much did Matisse Pharmaceuticals B.V raise?
- Matisse Pharmaceuticals B.V raised €14 Million in a Series A round on September 17, 2026.
- Who invested in Matisse Pharmaceuticals B.V?
- Liof and Brightlands Venture Partners are named as investors in this round.
- What does Matisse Pharmaceuticals B.V do?
- Matisse Pharmaceuticals B.V. is a clinical stage company founded in 2014 in Geleen, the Netherlands.
- Where is Matisse Pharmaceuticals B.V based and how big is it?
- Matisse Pharmaceuticals B.V is based in Limburg, Netherlands. Fundz records about 10 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Matisse Pharmaceuticals B.V that raised within 45 days of this round, from Fundz verified event records.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Trior raised $25M (Series C) on October 23, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
Who to call at Matisse Pharmaceuticals B.V, and when
A new round usually means Matisse Pharmaceuticals B.V is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Matisse Pharmaceuticals B.V raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Matisse Pharmaceuticals B.V, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Matisse Pharmaceuticals B.V. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Matisse Pharmaceuticals B.V raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansMatisse Pharmaceuticals B.V raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.